Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank78
3Y CAGR+30.7%
5Y CAGR-6.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+30.7%/yr
vs -10.7%/yr prior
5Y CAGR
-6.3%/yr
Recent acceleration
Acceleration
+41.4pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.58M | +11.0% |
| 2024 | $11.33M | -4.8% |
| 2023 | $11.90M | +111.3% |
| 2022 | $5.63M | -68.3% |
| 2021 | $17.78M | +1.8% |
| 2020 | $17.46M | +90.7% |
| 2019 | $9.15M | +3.6% |
| 2018 | $8.84M | +144.9% |
| 2013 | $3.61M | -10.7% |
| 2012 | $4.04M | - |